Tag: editorial

Oncotarget News

Oncotarget

Genotype Matters: Tailored Screening for Germline CHEK2 Variants

August 26, 2024

In our study, we postulated that these differences were driven by three common low-risk (LR) missense variants: p.I157T, p.S428F, and p.T476M, all of which have a BC... read more

Oncotarget

Disrupting NKG2A:HLA-E Interactions for Enhanced Anti-Cancer Immunity

August 21, 2024

there is strong preclinical evidence that disruption of NKG2A interactions with HLA-E can stimulate both NK cell and cytotoxic T cell effector functions against cancer.”BUFFALO, NY- August 21, 2024 –... read more

Oncotarget

Dealing with Runaway Metastatic Disease

August 7, 2024

Metastatic disease remains a major issue in daily practice in oncology because the outcome is still often fatal.”BUFFALO, NY - August 7, 2024 – A new editorial paper was published in... read more

Oncotarget

One More Step Toward Treatment of PARP Inhibitor-resistant Ovarian Cancers

January 10, 2024

This initiative is geared towards identifying additional biomarkers that can aid in selecting the most appropriate treatments for ovarian cancer.”BUFFALO, NY- January 10, 2024 – A new editorial paper was... read more

Oncotarget

Behind the Study: ER Expression Multiclonality in DCIS: Clinical & Future Insights

August 29, 2023

Dr. Mangesh A. Thorat from Guy’s Hospital in London, Queen Mary University of London, and King’s College London, describes a recent editorial he authored that was published by... read more

Oncotarget

Cancer-Associated Fibroblasts: Challenges and Opportunities

April 5, 2023

Beyond detection of cancer, CAFs are being actively pursued as targets for therapy.” BUFFALO, NY- April 5, 2023 – A new editorial perspective was published in Oncotarget's Volume 14 on... read more

Oncotarget

Oncotarget | Mitochondria Engage the Integrated Stress Response to Promote Tumor Growth

March 8, 2023

Overall, this research proposes a new paradigm on how AR-independent PCa can drive tumor traits by exploiting mitochondrial signaling pathways [...]” BUFFALO, NY- March 8, 2023 – A new editorial paper... read more